HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 60 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,533,153 | +9.2% | 290,911 | +17.2% | 0.00% | +50.0% |
| Q2 2023 | $8,733,278 | +19.5% | 248,175 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $7,310,629 | -41.2% | 223,909 | -0.8% | 0.00% | -50.0% |
| Q4 2022 | $12,435,629 | +9.8% | 225,692 | -11.7% | 0.00% | 0.0% |
| Q3 2022 | $11,325,000 | -1.3% | 255,706 | +8.7% | 0.00% | 0.0% |
| Q2 2022 | $11,478,000 | -9.4% | 235,324 | -9.6% | 0.00% | 0.0% |
| Q1 2022 | $12,669,000 | +11.3% | 260,391 | -2.5% | 0.00% | +33.3% |
| Q4 2021 | $11,387,000 | +28.0% | 267,049 | +15.1% | 0.00% | 0.0% |
| Q3 2021 | $8,894,000 | +564.7% | 232,029 | +389.8% | 0.00% | – |
| Q2 2021 | $1,338,000 | +194.1% | 47,377 | +244.1% | 0.00% | – |
| Q1 2021 | $455,000 | -2.8% | 13,767 | +6.3% | 0.00% | – |
| Q4 2020 | $468,000 | – | 12,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |